Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Peripheral Nervous System Diseases 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anorexia 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Olanzapine 3Ibuprofen 3Blood Specimen Collection 3anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1dermcidin 1clazakizumab 1bermekimab 1alkaloid GB18 1Vitamin D 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cachexia × nabilone × Clear all
NCT02802540 2016-08-31

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown
78 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡